Top Markets
Coin of the day
Comera Life Sciences Holdings, Inc. Comera Life Sciences Holdings, Inc.

Comera Life Sciences Holdings, Inc.

CMRAW
Clasificación en acciones #41593
Comera Life Sciences Holdings, Inc. is an early-stage life sciences company... Comera Life Sciences Holdings, Inc. is an early-stage life sciences company dedicated to developing its own innovative therapeutics. These treatments leverage its unique SQore formulation platform, which is engineered to convert biologics typically administered intravenously (IV) into convenient subcutaneous (SQ) versions. The company's pipeline currently features two primary drug candidates: CLS-001, an improved biologic in preclinical development, targets Crohn's and Ulcerative Colitis; and CLS-002, also in preclinical stages, is an enhanced biologic aimed at various oncological indications. Established in 2014, Comera Life Sciences is based in Woburn, Massachusetts.
Precio por acción
$0.0008
Última sincronización: 2024-03-14
Capitalización bursátil
$15.27K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Comera Life Sciences Holdings, Inc. (CMRAW)

Categoría

Ratio P/S de Comera Life Sciences Holdings, Inc. (CMRAW)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Comera Life Sciences Holdings, Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Comera Life Sciences Holdings, Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
9.88 -
US
10.30 -
NL
- -
CH
4.98 -
BE
- -
KR